Available online xxx a b s t r a c t Sodium Salicylate (SS) reliably induces a sensorineural hearing loss and tinnitus when administered in high doses. Recent animal modeled studies indicate that potassium channel openers such as Maxipost and Retigabine (RTG) can block SS-or noise-induced tinnitus respectively; however, the origins and mechanisms are poorly understood. Since SS blocks the same potassium channels that Maxipost and RTG open, we postulated that these drugs might influence peripheral auditory function. To test this hypothesis Maxipost or RTG were administered alone or in combination with SS in rats. When administered alone, Maxipost and RTG had no effect on distortion product otoacoustic emissions (DPOAE) or compound action potentials (CAPs). However when Maxipost or RTG were administered with SS, Maxipost prevented the SS-reduced CAP amplitudes at high frequencies (!20 kHz) and RTG prevented SS-reduced CAP amplitudes at low frequencies ( 8 kHz). These results suggest that Maxipost and RTG can protect against peripheral damage and therefore reduce the incidence of tinnitus.
Introduction
High-dose sodium salicylate (SS), the active ingredient in aspirin, reliably induces temporary sensorineural hearing loss, tinnitus (Bauer et al., 1999; Jastreboff et al., 1988; Lobarinas et al., 2004; Yang et al., 2007) and hyperacusis . Consequently, SS is frequently used to investigate peripheral and central mechanisms of hearing loss, tinnitus and hyperacusis in animal models. However, despite being used in auditory research for more than 50 years SS's mechanisms of action are still not fully understood.
SS has a profound influence on the cochlea, including a reduction in OHC electromotility and potassium currents. A significant reduction in distortion product otoacoustic emissions (DPOAEs) accompanies a high-dose SS injection in rats (Chen et al., 2010; Sheppard et al., 2014; . This reduction has been reported as frequency-specific . DPOAEs arise from prestin-mediated outer hair cell (OHC) electromotility, supported in part by the þ80 mV endocochlear potential and high potassium concentration in endolymph (Liberman et al., 2002; Schmiedt et al., 2002) . SS competitively suppresses the binding of chloride to anion binding sites on the motor protein prestin (Oliver et al., 2001; Rybalchenko and Santos-Sacchi, 2003) , thereby reducing the electromotility of OHCs. SS also blocks potassium (K þ ) currents on cochlear sensory cells. Within inner hair cells (IHCs), SS blocks the outward K þ current (I k,f ), but does not affect the inward potassium current (I k,n ) in guinea-pigs (Kimitsuki et al., 2011) . Based on its sensitivity to iberiotoxin and charybdotoxin (BK blockers), the K þ current I k.f represents the large conductance Ca 2þ -and voltage-activated BK channels (Kros and Crawford, 1990; Kros et al., 1998) . Within OHCs, SS blocks the K þ channel KCNQ4 (Kv7.4) in guinea-pig, which has been suggested as the molecular correlate of the potassium current I k.n (Housley and Ashmore, 1992; Wu et al., 2010) . K þ channels have different expression levels along the tonotopic gradient of the mouse and rat cochlea (Beisel et al., 2000; Engel et al., 2006; Hafidi et al., 2005; Kharkovets et al., 2000; Wersinger et al., 2010) . Therefore, SS blockage of BK or Kv7.4 could contribute to a frequency-dependent reduction in compound action potentials (CAPs) or DPOAEs. The K þ ion channel openers BMS-204352 (Maxipost) and Retigabine (RTG) were originally developed for stroke (Gribkoff et al., 2001a, b) Q1 and epilepsy (Rostock et al., 1996) , respectively. However, they also have anxiolytic (Korsgaard et al., 2005) , antinociceptive (Blackburn-Munro and Jensen, 2003; Nodera et al., 2011) , and neuroprotective properties (Jensen, 2002; Rundfeldt, 1997) , resulting from Kv7 and BK K þ channel activation. These 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55 potassium channels are present in the CNS (Brenner et al., 2005; Hansen et al., 2006; Korsgaard et al., 2005; Sausbier et al., 2006) and on cochlear hair cells of mice and rats with varying expression along the tonotopic gradient (Beisel et al., 2000; Hafidi et al., 2005; Kharkovets et al., 2006) . Mutations in four of five known Kv7 potassium channel subunits cause human-inherited diseases, some of which are characterized by central hyperactivity and peripheral deafness (Maljevic et al., 2010) . Since tinnitus has been hypothesized as a central hyperactivity disorder, potassium channel openers have been evaluated for their efficacy in suppressing SSand noise-induced tinnitus in both mice and rats (Li et al., 2013; Lobarinas et al., 2011) . Maxipost eliminates SS-induced tinnitus in rats (Lobarinas et al., 2011) , while RTG prevents noise-induced tinnitus in mice (Li et al., 2013) . However, these mechanisms are not well understood.
In the present study, we characterize the influence that Maxipost and RTG have on the peripheral auditory system alone and in combination with SS using a rat animal model. Since Kv7 and BK channels are abundantly expressed in the peripheral system of murine species, and are blocked by SS, we hypothesized that Maxipost and/or RTG would enhance the gross cochlear potentials alone or in combination with SS. Alterations occurring in the periphery as a result of these drugs can elucidate the role of potassium channels in cochlear function and SS-induced ototoxicity.
Materials and methods

Subjects
Seventy-seven male SpragueeDawley rats (250e500 g, Charles River) between the ages of 2e5 months were used in this study. Animals were housed two per cage, provided free access to food and water, and kept on a 12/12 h lightedark cycle. For CAP measurements (n ¼ 48), animals were randomly assigned into eight groups: Control (n ¼ 6), vehicles (Saline n ¼ 6), or dimethyl sulfoxide (DMSO, n ¼ 6), SS (n ¼ 6), Maxipost (n ¼ 6), RTG (n ¼ 6), Maxipost þ SS (n ¼ 6), and RTG þ SS (n ¼ 6). For DPOAE measurements (n ¼ 29), animals were randomly assigned to seven groups: vehicles (Saline n ¼ 4, or DMSO n ¼ 6), SS (n ¼ 3), Maxipost (n ¼ 4), RTG (n ¼ 4), Maxipost þ SS (n ¼ 4), and RTG þ SS (n ¼ 4).
Compound action potentials
Rats were anesthetized with a ketamine (60 mg/kg) and xylazine (6 mg/kg) injection intraperitoneally (i.p.). Body temperature was maintained at 37 C using a homoeothermic blanket (Harvard Apparatus, Holliston, MA). The animal was placed in a custom head-holder, the right bulla was exposed and a small fistula made to access the cochlear round window. A Teflon-coated gold wire (76.2 mm in diameter, Cat#75810, AeM System Inc.) ring-electrode was placed on the round window and a silver chloride reference electrode was inserted into the neck muscles. The tone bursts (2, 4, 6, 8, 12, 16, 20, 24, 30, 35, & 40 kHz) were generated using a Tucker Davis Technologies (TDT) real-time processor (RP2.1, System 3, TDT; Alachua, FL). The signal (duration: 20 ms; rise/fall time: 1 m) was presented via a high frequency transducer crafted from an ACO ½ 00 microphone. Stimulation intensities decreased in 10 dB steps from 80 dB SPL using a TDT PA5 programmable attenuator. The cochlear response within a 20 ms time window was amplified (1000x) with a Grass AC preamplifier (Model P15; West Warwick, RI, USA) and filtered online (0.1e50 kHz) using a custom MATLAB program. The CAP component was isolated off-line by low-pass filtering 1 kHz below the stimulation frequency. The vertical distance between N1 and P1 was measured and used to represent the CAP amplitude. Data were plotted and analyzed with GraphPad software. CAP threshold was defined as the stimulus intensity that elicited a 4 mV N1 response. Responses were discarded if a reduction in stimulation level did not result in reduced amplitude measurement and demonstrated poor waveform morphology suggestive of electrical noise. Changes in CAP amplitude I/O functions following treatment were tested for significance using two-way ANOVA, and changes in CAP thresholds were tested for significance using one-way ANOVA (Prism GraphPad v5).
Distortion product otoacoustic emissions
Rats were anesthetized with a ketamine (60 mg/kg) and xylazine (6 mg/kg) injection (i.p.). Using a commercial instrument (Intelligent Hearing Systems; Miami, FL), DPOAEs were obtained with two primary tones (f1 and f2) presented at an f2/f1 ratio of 1.2. The intensity of f1 (L1) was presented 10 dB higher than the intensity of f2 (L2). I/O functions for distortion products 2f1ef2 were plotted for f2 frequencies of 4, 6, 8.6, 13.2, 16, 24, 30 and 35 kHz using L1 intensities of 25e80 dB SPL (5 dB steps). I/O functions were analyzed for significance using two-way ANOVA (Prism GraphPad v5).
Experimental conditions
Experiment 1: vehicles (DMSO & saline)
Saline was used to dissolve SS and DMSO (SigmaeAldrich, St. Louis, MO) was used to dissolve Maxipost and RTG. One vehicle group was treated with saline alone and the other vehicle group was treated with DMSO alone. CAPs and DPOAEs were acquired 3 h later.
Experiment 2: SS
SS (SigmaeAldrich) was dissolved in saline (50 mg/ml), and administered via i.p injection (200 mg/kg).This dose reliably induces tinnitus and hearing loss (Chen et al., 2013; Lobarinas et al., 2004; Sheppard et al., 2014; . For DPOAEs, a within-subject experiment, measurements were made at baseline and 3 h post SS. For CAPs, a between-group experiment, recordings were performed 3 h post SS.
Experiment 3: Maxipost or RTG alone
Maxipost (Axon Medchem, 9713 GZ Groningen, The Netherlands) was dissolved in DMSO (25 mg/ml) and administered via i.p. injection (10 mg/kg). Previous reports indicate this dose eliminated behavioral evidence of SS-induced tinnitus in rats (Lobarinas et al., 2011) . RTG (Alomone Labs, Har Hotzvim Hi-Tech Park, P.O.Box 4287 Jerusalem 9104201, Israel) was dissolved in DMSO (50 mg/ml) and administered via i.p. injection (10 mg/kg). Previous reports indicate this dose prevents noise-induced tinnitus in mice (Li et al., 2013) . DPOAEs were obtained at baseline and again 2 h post Maxipost or RTG. CAPs were obtained approximately 3 h post drug administration.
Experiment 4: Maxipost or RTG þ SS
Maxipost or RTG (10 mg/kg i.p.) was administered 10 min prior to SS (200 mg/kg i.p.). DPOAEs or CAPs were obtained 3 h later.
Compliance
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Vehicles
Fig . 1A illustrates CAP amplitudes as a function of tone bursts presented at 80 dB SPL for control, saline, and DMSO groups. Fig. 1B illustrates DPOAEs as function of f2 frequencies with L1 intensity set at 70 dB SPL for control, saline, and DMSO groups. There is no significant difference between control and vehicle (saline and DMSO) treated animals. This indicates that the vehicles used had no significant impact on peripheral hearing.
SS
It is well-established that SS is ototoxic (Chen et al., 2010 (Chen et al., , 2013 Stolzberg et al., 2012) . Fig. 2A illustrates that mean (þ/ÀSEM) CAP thresholds were significantly higher than saline vehicles by approximately 30 dB SPL across the tested frequency range (twoway ANOVA, p ¼ 0.0001, F 1,10 ¼ 205). Fig. 2B illustrates mean (þ/ÀSEM) CAP I/O functions at 6, 20 and 35 kHz. The average CAP amplitudes decreased significantly at all frequencies 3 h post SS (two-way ANOVA, 4 kHz p < 0.001, F 1,2 ¼ 13.17; 6e40 kHz p < 0.0001, F 1,4 ¼ 13e37). Fig. 2C illustrates mean (þ/À SEM) DPOAE I/O functions 3 h post SS. DPOAEs were significantly reduced at all tested frequencies (two-way ANOVA, 4e24 kHz p < 0.0001, F 1,11 ¼ 18e40; 30 kHz p < 0.02, F 1,7 ¼ 5.948; 35 kHz p < 0.04, F 1,11 ¼ 4.212). These results indicate that SS induced a mild-tomoderate CAP threshold shift, moderately decreased CAP amplitudes, and mildly reduced DPOAEs, indicative of OHC dysfunction. Fig. 4A illustrates CAP thresholds for Maxipost þ SS and SS alone. Maxipost þ SS was not significantly different from SS alone (one-way ANOVA, p > 0.05). Fig. 5B illustrates mean DPOAE I/O functions for Maxipost þ SS and SS alone. There was no significant difference between Maxipost þ SS and SS alone (two-way ANOVA, p > 0.05). Since Maxipost reversed SS-reduced CAP amplitudes, but not DPOAEs, these data suggest that Maxipost inhibits SS-induced K þ channel blockage of IHCs in the basal high-frequency region of the cochlea.
Maxipost and RTG alone
RTG and SS
Fig . 6A illustrates mean (þ/À SEM) CAP I/O functions at a low (6 kHz), mid (16 kHz), and high (35 kHz) frequency for RTG þ SS and SS alone groups. For reference, data are shown for saline and DMSO vehicles. Compared to SS alone, RTG þ SS significantly enhanced mean CAPs in low frequencies 8 kHz (two-way ANOVA, 2 kHz: p < 0.05, F 1,1 ¼ 6.215; 4 kHz: p < 0.05, F 1,2 ¼ 4.84; 6 kHz: p < 0.0001,F 1,4 ¼ 18.92; 8 kHz: p < 0.01, F 1,3 ¼ 9.796), but not in mid or high frequencies !12 kHz. Fig. 4B illustrates that CAP thresholds in the low frequencies were significantly reduced in RTG þ SS compared to SS alone (one-way ANOVA, 2 kHz: p < 0.01, F 3,4 ¼ 8.899; 4 kHz: p < 0.05, F 3,4 ¼ 5.462; 6 kHz: p < 0.05, F 3,4 ¼ 10.42; 8 kHz: p < 0.01, F 3,4 ¼ 20.22). Additionally, CAP thresholds were not significantly different between saline and RTG þ SS (two-way ANOVA, p > 0.05: 2 kHz, 4 kHz, 6 kHz, & 8 kHz), indicating that RTG completely reversed the SS-induced threshold shift in low frequencies. Fig. 6B illustrates mean DPOAE I/O functions for RTG þ SS and SS alone. Results indicate no significant difference between RTG þ SS and SS alone in all tested frequencies (two-way ANOVA, p > 0.05). Since RTG reversed SS-reduced CAP amplitudes, but not DPOAEs, these data suggest that RTG inhibits SS K þ channel blockage in the apical low-frequency region of the cochlea.
Discussion
Salicylate pathophysiology of Kv7.4 and BK K þ channels
Previous research using knockout mouse models have determined that BK and Kv7.4 channel function is essential for normal hearing (Kharkovets et al., 2006; Ruttiger et al., 2004 ), although 5.3, 6, 12, 16, 20, 24, 30, 35 kHz) . Presented data includes control animals (n ¼ 6), and vehicles animals, saline (n ¼ 6) or DMSO (n ¼ 6), (ns ¼ not significant).
A.M. Sheppard et al. / Hearing Research xxx (2015) 1e8 3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 their direct mechanisms are not well understood. It is speculated that Kv7.4 modulates the resting potential, and therefore excitation of sensory cells through removal of intracellular K þ at the basal pole of OHCs (Kubisch et al., 1999) . This theory is supported by the basal pole location of Kv7.4 on OHCs (Kharkovets et al., 2000) . Salicylate blocks Kv7.4, reduces K þ conductance, and subsequently depolarizes guinea-pig OHCs (Wu et al., 2010) . This depolarization could reduce the net driving force for K þ influx, and subsequently reduce electromotility of OHCs (Wu et al., 2010) , resulting in increased thresholds. BK channel function in the mammalian 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66 cochlea is unclear but they may play a role in modulating neurotransmitter release (Skinner et al., 2003) . This theory is supported by the observation that specific BK channel blockers, charybdotoxin (ChTX) and iberiotoxin (IbTX), significantly reduce sound-evoked cochlear CAPs in guinea pigs (Skinner et al., 2003) . Salicylate blocks the IHC BK sensitive K þ current I K,f (Kimitsuki et al., 2011) , which plays a role in cellular high frequency transduction by accelerating membrane repolarization (Kros and Crawford, 1990 ).
This suggests that salicylate-induced high-frequency hearing loss is due to blocking BK channels, causing impaired IHC repolarization and therefore reduced transmitter release.
High frequency Maxipost protection at BK channels
Our results suggest that Maxipost protection from SS results from an opening action on BK channels in the basal region of the A.M. Sheppard et al. / Hearing Research xxx (2015) 1e8 5   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66 cochlea. BK channels are likely the primary contributor since they are blocked by salicylate (Kimitsuki et al., 2011) , opened by Maxipost, but not RTG (Jensen, 2002; Korsgaard et al., 2005; Tatulian et al., 2001) , and are primarily expressed in the high frequency region of the cochlea (Kimitsuki et al., 2003; Wersinger et al., 2010) . Previous studies demonstrate BKaÀ/À mice develop a progressive high-frequency hearing loss (Ruttiger et al., 2004) . SS-induced BK channel blockage could impose a similar hearing loss and be reversed by treatment with a BK channel opener, such as Maxipost. Fig. 7A speculates the antagonistic influences that SS and Maxipost have on BK channels in the basal region of cochlea and illustrates mean CAP waveforms obtained from saline, SS alone, and Maxipost þ SS to a high frequency stimuli (35 kHz).
Low frequency Retigabine protection at Kv7.4 channels
Our results suggest that RTG protection from SS results from an opening action on Kv7.4 channels in the apical region of the cochlea. Both Maxipost and RTG open Kv7.4 channels (Schroder et al., 2001) ; however, RTG has a higher affinity for Kv7.4 than Maxipost (Jensen, 2002; Korsgaard et al., 2005; Schroder et al., 2001) . Salicylate blocks OHC Kv7.4 currents (Wu et al., 2010) , which are primarily expressed on OHCs in the apical region of the cochlea (Beisel et al., 2000) . Previous studies indicate that Kv7.4À/À mice develop hearing loss with elevated ABR thresholds and reduced DPOAEs (Kharkovets et al., 2006) , suggestive of OHC dysfunction. Therefore, SS-induced Kv7.4 blockage could impose a similar hearing loss and be reversed by treatment with a Kv7.4 channel opener, such as RTG. In contradiction, in the present study, RTG failed to reverse SSreduced DPOAEs, suggesting that RTG protection was not mediated at the level of OHCs. Additional studies using more sensitive measures such as whole-cell patch clamping are needed for further clarification. Fig. 7C speculates the antagonistic influence that SS and RTG have on Kv7.4 channels in the apical region of the cochlea and demonstrates mean CAP waveforms obtained from saline, SS alone, and RTG þ SS to a low frequency stimuli (6 kHz).
Tinnitus and potassium channel openers
While chronic tinnitus is generated, at least partially, within the CNS (House and Brackmann, 1981) , the peripheral auditory system plays a role in precipitating tinnitus onset (Bartels et al., 2007; Salvi et al., 2000) . Therefore, considering the results of the current study, Maxipost or RTG might prevent tinnitus generation by reducing peripheral damage. RTG would suppress low-frequency tinnitus, while Maxipost, in contrast, would suppress high frequency tinnitus. Since SS is believed to induce a high pitched tinnitus (Jastreboff and Sasaki, 1994; Lobarinas et al., 2004; Yang et al., 2007) , these results explain why Maxipost was effective at preventing SS-induced tinnitus (Lobarinas et al., 2011) .
Maxipost and RTG also influence the CNS (Brenner et al., 2005; Gribkoff et al., 2001a, b; Li et al., 2013) . Maxipost has cortical Fig. 6 . RTG protects against SS-induced low-frequency amplitude reduction in CAPs, but not DPOAEs. (A) CAP amplitudes from RTG þ SS and SS at a low-mid-and high-frequency. RTG þ SS significantly protected against SS-reduced CAP amplitudes in low-frequencies (two-way ANOVA, *** ¼ p < 0.001, ns ¼ not significant). (B) DPOAEs from RTG þ SS and SS at a low-mid-and high-frequency. There was no significant difference in DPOAE amplitudes between RTG þ SS and SS across the frequency spectrum (two-way ANOVA, p > 0.05, ns ¼ not significant). Dashed lines represent saline vehicle and dotted lines represent DMSO vehicle for reference.
A.M. Sheppard et al. / Hearing Research xxx (2015) 1e8  6   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 neuroprotective properties (Gribkoff et al., 2001a, b; Jensen, 2002) and regulates neurotransmitters important for excitation (Jensen, 2002) . RTG suppresses noise-induced spontaneous hyperactivity in high frequency fusiform cells of the dorsal cochlear nucleus in vitro (Li et al., 2013) . Therefore, more detailed research is needed to characterize the effects that Maxipost and RTG have on central auditory structures involved with tinnitus perception.
Summary
Consistent with previous studies, our results indicate that CAP amplitudes are suppressed and thresholds increased 3 h after a high dose of SS (Chen et al., 2010; Sun et al., 2009) . Recent studies suggest that this observation results in part by SS blockage of BK and Kv7.4 K þ channels (Kimitsuki et al., 2011; Wu et al., 2010) . Combined treatment of Maxipost or RTG with SS partially or completely reversed SS-reduced CAP amplitudes and thresholds. Maxipost protection was observed in the basal high frequency region (!20 kHz), and RTG protection was observed in the apical low frequency region ( 8 kHz). These results are likely due to (1) the tonotopic dependent expression of K þ channels in the cochlea, and (2) the antagonistic influence of SS (blocking K þ channels) and Maxipost or RTG (opening K þ channels).
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